Epigenetics disruptions enabled by porphyrin-derived metal-organic frameworks disarm resistances to sonocatalytic ROS anti-tumor actions

Post-transcriptional epigenetic modifications provide numerous implications for tumor progression, metastasis and recurrence, which also pose resistances to reactive oxygen species (ROS)-based anti-tumor. Herein, we proposed an epigenetic deubiquitination disruption strategy to disarm the ubiquitina...

Full description

Saved in:
Bibliographic Details
Main Authors: Yan Zhang, Dou Du, Chao Fang, Xin Yu, Yujia Fang, Xinyu Liu, Di Ou, Haohao Yin, Hui Liu, Taixia Wang, Lu Lu, Xiaolong Li, Kun Zhang
Format: Article
Language:English
Published: KeAi Communications Co. Ltd. 2025-01-01
Series:Fundamental Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2667325822002977
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832583004429484032
author Yan Zhang
Dou Du
Chao Fang
Xin Yu
Yujia Fang
Xinyu Liu
Di Ou
Haohao Yin
Hui Liu
Taixia Wang
Lu Lu
Xiaolong Li
Kun Zhang
author_facet Yan Zhang
Dou Du
Chao Fang
Xin Yu
Yujia Fang
Xinyu Liu
Di Ou
Haohao Yin
Hui Liu
Taixia Wang
Lu Lu
Xiaolong Li
Kun Zhang
author_sort Yan Zhang
collection DOAJ
description Post-transcriptional epigenetic modifications provide numerous implications for tumor progression, metastasis and recurrence, which also pose resistances to reactive oxygen species (ROS)-based anti-tumor. Herein, we proposed an epigenetic deubiquitination disruption strategy to disarm the ubiquitination-deubiquitination balance-induced resistances to ROS production and ROS-based anti-tumor action for potentiating sonodynamic treatment (SDT) efficiency. To end it, porphyrin-derived metal-organic framework (MOF) sonocatalytic nanoplatforms were developed to load deubiquitination inhibitors (i.e., Auranofin). Ultrasound-triggered Auranofin release from PCN224@Au has been validated to blockade the deubiquitinating process and drive proteasome-mediated target protein degradation. The epigenetic deubiquitination disruption not only synergized with MOF-mediated sonocatalytic ROS production, but also inactivate deubiquitinating enzymes, blockade the deubiquitination process and further remove these resistances, both of which mutually behaved as reciprocal impetuses to significantly magnify SDT outcomes against liver cancers. Such a deubiquitination-engineered disruption approach finds an unprecedented pathway to disarm deubiquitination-induced resistances to SDT and other ROS-based anti-tumor means, which also enlightens us to establish other post-transcriptional epigenetic modification disruption strategies to re-program the tumor microenvironment and elevate the anti-tumor efficiency of various treatment methods (e.g., immunotherapy).
format Article
id doaj-art-24df479fa79d452b8c7fae85c237aff6
institution Kabale University
issn 2667-3258
language English
publishDate 2025-01-01
publisher KeAi Communications Co. Ltd.
record_format Article
series Fundamental Research
spelling doaj-art-24df479fa79d452b8c7fae85c237aff62025-01-29T05:02:25ZengKeAi Communications Co. Ltd.Fundamental Research2667-32582025-01-0151296306Epigenetics disruptions enabled by porphyrin-derived metal-organic frameworks disarm resistances to sonocatalytic ROS anti-tumor actionsYan Zhang0Dou Du1Chao Fang2Xin Yu3Yujia Fang4Xinyu Liu5Di Ou6Haohao Yin7Hui Liu8Taixia Wang9Lu Lu10Xiaolong Li11Kun Zhang12Central Laboratory, Ultrasound Research and Education Institute, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Tongji University, Shanghai 200072, ChinaCentral Laboratory, Ultrasound Research and Education Institute, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Tongji University, Shanghai 200072, ChinaCentral Laboratory, Ultrasound Research and Education Institute, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Tongji University, Shanghai 200072, ChinaDepartment of Medical Oncology, Shanghai Pulmonary Hospital, Thoracic Cancer Institute, Tongji University School of Medicine, Tongji University, Shanghai 200433, ChinaDepartment of Medical Oncology, Shanghai Pulmonary Hospital, Thoracic Cancer Institute, Tongji University School of Medicine, Tongji University, Shanghai 200433, ChinaDepartment of Medical Oncology, Shanghai Pulmonary Hospital, Thoracic Cancer Institute, Tongji University School of Medicine, Tongji University, Shanghai 200433, ChinaCentral Laboratory, Ultrasound Research and Education Institute, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Tongji University, Shanghai 200072, ChinaCentral Laboratory, Ultrasound Research and Education Institute, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Tongji University, Shanghai 200072, ChinaCentral Laboratory, Ultrasound Research and Education Institute, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Tongji University, Shanghai 200072, ChinaCentral Laboratory, Ultrasound Research and Education Institute, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Tongji University, Shanghai 200072, ChinaCentral Laboratory, Ultrasound Research and Education Institute, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Tongji University, Shanghai 200072, ChinaCentral Laboratory, Ultrasound Research and Education Institute, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Tongji University, Shanghai 200072, ChinaCentral Laboratory, Ultrasound Research and Education Institute, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Tongji University, Shanghai 200072, China; Corresponding author.Post-transcriptional epigenetic modifications provide numerous implications for tumor progression, metastasis and recurrence, which also pose resistances to reactive oxygen species (ROS)-based anti-tumor. Herein, we proposed an epigenetic deubiquitination disruption strategy to disarm the ubiquitination-deubiquitination balance-induced resistances to ROS production and ROS-based anti-tumor action for potentiating sonodynamic treatment (SDT) efficiency. To end it, porphyrin-derived metal-organic framework (MOF) sonocatalytic nanoplatforms were developed to load deubiquitination inhibitors (i.e., Auranofin). Ultrasound-triggered Auranofin release from PCN224@Au has been validated to blockade the deubiquitinating process and drive proteasome-mediated target protein degradation. The epigenetic deubiquitination disruption not only synergized with MOF-mediated sonocatalytic ROS production, but also inactivate deubiquitinating enzymes, blockade the deubiquitination process and further remove these resistances, both of which mutually behaved as reciprocal impetuses to significantly magnify SDT outcomes against liver cancers. Such a deubiquitination-engineered disruption approach finds an unprecedented pathway to disarm deubiquitination-induced resistances to SDT and other ROS-based anti-tumor means, which also enlightens us to establish other post-transcriptional epigenetic modification disruption strategies to re-program the tumor microenvironment and elevate the anti-tumor efficiency of various treatment methods (e.g., immunotherapy).http://www.sciencedirect.com/science/article/pii/S2667325822002977Epigenetics engineeringUbiquitylation modulationSonocatalysisReactive oxygen species resistanceAnti-tumor action
spellingShingle Yan Zhang
Dou Du
Chao Fang
Xin Yu
Yujia Fang
Xinyu Liu
Di Ou
Haohao Yin
Hui Liu
Taixia Wang
Lu Lu
Xiaolong Li
Kun Zhang
Epigenetics disruptions enabled by porphyrin-derived metal-organic frameworks disarm resistances to sonocatalytic ROS anti-tumor actions
Fundamental Research
Epigenetics engineering
Ubiquitylation modulation
Sonocatalysis
Reactive oxygen species resistance
Anti-tumor action
title Epigenetics disruptions enabled by porphyrin-derived metal-organic frameworks disarm resistances to sonocatalytic ROS anti-tumor actions
title_full Epigenetics disruptions enabled by porphyrin-derived metal-organic frameworks disarm resistances to sonocatalytic ROS anti-tumor actions
title_fullStr Epigenetics disruptions enabled by porphyrin-derived metal-organic frameworks disarm resistances to sonocatalytic ROS anti-tumor actions
title_full_unstemmed Epigenetics disruptions enabled by porphyrin-derived metal-organic frameworks disarm resistances to sonocatalytic ROS anti-tumor actions
title_short Epigenetics disruptions enabled by porphyrin-derived metal-organic frameworks disarm resistances to sonocatalytic ROS anti-tumor actions
title_sort epigenetics disruptions enabled by porphyrin derived metal organic frameworks disarm resistances to sonocatalytic ros anti tumor actions
topic Epigenetics engineering
Ubiquitylation modulation
Sonocatalysis
Reactive oxygen species resistance
Anti-tumor action
url http://www.sciencedirect.com/science/article/pii/S2667325822002977
work_keys_str_mv AT yanzhang epigeneticsdisruptionsenabledbyporphyrinderivedmetalorganicframeworksdisarmresistancestosonocatalyticrosantitumoractions
AT doudu epigeneticsdisruptionsenabledbyporphyrinderivedmetalorganicframeworksdisarmresistancestosonocatalyticrosantitumoractions
AT chaofang epigeneticsdisruptionsenabledbyporphyrinderivedmetalorganicframeworksdisarmresistancestosonocatalyticrosantitumoractions
AT xinyu epigeneticsdisruptionsenabledbyporphyrinderivedmetalorganicframeworksdisarmresistancestosonocatalyticrosantitumoractions
AT yujiafang epigeneticsdisruptionsenabledbyporphyrinderivedmetalorganicframeworksdisarmresistancestosonocatalyticrosantitumoractions
AT xinyuliu epigeneticsdisruptionsenabledbyporphyrinderivedmetalorganicframeworksdisarmresistancestosonocatalyticrosantitumoractions
AT diou epigeneticsdisruptionsenabledbyporphyrinderivedmetalorganicframeworksdisarmresistancestosonocatalyticrosantitumoractions
AT haohaoyin epigeneticsdisruptionsenabledbyporphyrinderivedmetalorganicframeworksdisarmresistancestosonocatalyticrosantitumoractions
AT huiliu epigeneticsdisruptionsenabledbyporphyrinderivedmetalorganicframeworksdisarmresistancestosonocatalyticrosantitumoractions
AT taixiawang epigeneticsdisruptionsenabledbyporphyrinderivedmetalorganicframeworksdisarmresistancestosonocatalyticrosantitumoractions
AT lulu epigeneticsdisruptionsenabledbyporphyrinderivedmetalorganicframeworksdisarmresistancestosonocatalyticrosantitumoractions
AT xiaolongli epigeneticsdisruptionsenabledbyporphyrinderivedmetalorganicframeworksdisarmresistancestosonocatalyticrosantitumoractions
AT kunzhang epigeneticsdisruptionsenabledbyporphyrinderivedmetalorganicframeworksdisarmresistancestosonocatalyticrosantitumoractions